BeiGene
Factsheet describing the effectiveness and safety of a BTKi treatment in patients with relapsed/refractory chronic lymphocytic leukemia (R/R CLL).
BeiGene
Slide kit outlining a new therapeutic approach for previously untreated chronic lymphocytic leukemia (CLL)

Chatta med BeiGene

Stäng